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Original Article 
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Background and Objectives: Low HDL concentrations are considered an important risk factor for cardiovascu-
lar disease. Interventions promoting a low-fat, plant-based eating pattern appear to reduce CVD risk while para-
doxically also reducing HDL concentrations. Recent studies show HDL to comprise a range of subfractions, but 
the role these play in ameliorating the risk of CVD is unclear. The purpose of this study was to characterise 
changes in HDL subfractions in participants where HDL decreased following the CHIP intervention which pro-
motes a low-fat, plant-based diet, with physical activity. Methods and Study Design: Individuals (n=22; mean 
age=55.4±16.3 years; 45.5% men, 54.5% women) participating in a CHIP intervention were assessed at baseline 
and 30 days for changes in BMI, blood pressure, lipid profile, (including large-, intermediate- and small-HDL 
subfractions) and fasting glucose. Results: HDL significantly decreased (10.6%, p<0.001) together with BMI 
(2.5%, p=0.028), systolic blood pressure (7.1%, p=-0.005), total cholesterol (9.5%, p=0.002), LDL (11.2%, 
p=0.007) and fasting glucose (8.2%, p=0.028). Triglycerides (TG) did not significantly change. Physical activity 
(22.7%, p=0.016) and consumption of whole plant-foods (13.9%, p=0.003) significantly increased, while non-
plant (energy and animal) foods decreased (43.1%, p=0.009). Large-, intermediate- and small-HDL decreased (-
10.0%, p=0.003; -8.3%, p=0.013 and 22%, p=0.005, respectively). Conclusions: This paper discusses specific 
changes in HDL subfractions when overall-HDL decreases as a response to low fat, whole-food, plant-based eat-
ing and exercise. Additional research is required to elucidate the reasons through which behavioural therapies re-
model the HDL particle and how this impacts the functional properties of HDL and CVD risk. 
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INTRODUCTION 
Population studies have shown an inverse association 
between HDL concentrations and CVD.1 Consequentially, 
the National Cholesterol Education Program has advocat-
ed increasing HDL concentrations as an important strate-
gy for the primary prevention of CVD.2 The consistently 
strong inverse association between low HDL concentra-
tions and the risk of cardiovascular events observed in 
epidemiological studies have traditionally been explained 
by its role in reverse cholesterol transport (RCT) from 
peripheral tissue to liver, also known as cholesterol ef-
flux.3 In addition, HDL protects LDL from oxidation, and 
has anti-atherogenic properties, mediated by various anti-
inflammatory, anti-apoptotic, anti-thrombotic, vasodilato-
ry and anti-infection mechanisms.4  
Despite these documented anti-atherogenic properties, 
there is conflicting evidence that questions the simple 
direct relationship between HDL concentrations and risk 
of cardiovascular events. For example, many individuals 
who suffer coronary atherosclerotic events have normal 
or even elevated HDL concentrations.5 Furthermore, 
when HDL concentrations are raised pharmacologically, 
they do not always correlate with reduced risk of coro-
nary heart disease (CHD).6 Other epidemiological studies  
 
 
have shown that individuals who consume a low fat, 
plant-based diet are at lower risk of CVD and type 2 dia-
betes mellitus, despite having lowered HDL concentra-
tions.7,8 Patients placed on a behaviour change interven-
tion, that incorporated this dietary regime, showed im-
provement in measured coronary artery percent diameter 
stenosis and symptomatic angina, despite reductions in 
HDL concentrations.9  
The value of pharmacologically increasing HDL con-
centrations alone has been further questioned as the di-
verse functions of HDL have become better under-
stood.5,10 Recent studies have shown HDL to be more 
complicated in both structure and function than first 
thought. Fractionation by ultracentrifugation has shown 
that human HDL can be largely separated into two major 
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subfractions, HDL2 (large HDL) and HDL3 (small HDL), 
with further subpopulations existing within these subfrac-
tions.4 These subpopulations exhibit substantial differ-
ences in their array of lipids (lipidome) and proteins (pro-
teome) resulting in variations in size, density, structure 
and composition, as well as metabolic and functional 
roles.11 These particles undergo continuous remodelling 
through interactions with various enzymes, lipid transfer 
proteins and cell surface proteins.11  
There is currently no consensus as to the clinical bene-
fits of the various HDL subfractions. Several large-scale 
epidemiologic studies have investigated the risk of CHD 
when HDL was separated by size. In some studies, the 
smaller, denser HDL3 particles are associated with fa-
vourable atheroprotective functions and clinical outcomes, 
including protection from CHD.11-13 In others, the lighter 
large HDL particles appear to be linked to antiatherogenic 
functions,14 and are inversely associated with hyperten-
sion,15 CHD and atherosclerosis.16,17 Furthermore, Aszta-
los et al,18 suggested that the large HDL subfraction is 
inversely associated with disease burden, while the role of 
small HDL is unclear, proposing that some particles in 
the subpopulation are atheroprotective, and others are 
positively associated with CVD.  
While the positive association of diet modification (e.g. 
low calorie, low fat, vegetable rich) with reduced cardio-
vascular risk is well documented, the relationship of this 
dietary change to changes in HDL subfractions has not 
been previously investigated. Recently we reported that 
when individuals underwent the CHIP intervention, 
which incorporates a low-fat, plant-based diet, average 
HDL concentrations decreased despite improvements in 
all other measured markers of cardiovascular risk includ-
ing blood pressure, BMI, total cholesterol (TC), LDL, TG 
and fasting plasma glucose (FPG).19 The purpose of this 
study was to therefore characterise the changes in HDL 
subfractions in individuals participating in the CHIP in-
tervention, where HDL decreased. 
 
METHODS 
Participants 
This study, without a reference group, evaluated the pre- 
to post-biometric changes of 30 individuals (mean age 
56.4 ±15.1; 40% men, 60% women) who self-selected to 
participate in a CHIP intervention conducted in a com-
munity center in New South Wales, Australia. Following 
the intervention, HDL was found to decrease in 22 indi-
viduals (mean age=55.4±16.3 years; 45.5% men, 54.5% 
women), and increase in eight individuals (mean age 
59.3±11.6, 25% men, 75% women). The difference in age 
was not statistically significant (p=0.542). There were no 
inclusion/exclusion criteria other than the participant be-
ing able to pay a $AUD399 program cost. Participants 
were invited to attend the intervention through word of 
mouth invitation, local media avenues and advertising 
through local health care providers. Consent for the study 
was obtained from Avondale College of Higher Educa-
tion Human Research Ethics Committee (Approval No. 
20:10:07). As the purpose of this study was to explore 
changes in HDL subfractions among participants of the 
CHIP intervention, only those individuals whose HDL 
decreased were included in the analysis.  
Intervention 
The CHIP intervention is a well-published intervention 
shown to reduce selected risk factors associated with 
chronic disease.20 Volunteers who had previously under-
taken an eight-hour training course facilitated the inter-
vention. The intervention involved 12 group sessions over 
4 weeks, conducted in a community hall. Each session 
was approximately 1.5 hours in duration and involved 
viewing a pre-recorded lecture presented by a health ex-
pert, cooking demonstrations and interactive group activi-
ties. The intervention had a nutrition focus, but the con-
tent of the program also addressed physical activity (ad-
vocating at least 30 minutes or 10,000 steps as measured 
by pedometers supplied to each participant) and elements 
from the positive psychology literature such as stress 
management and emotional wellbeing.  
The eating pattern prescribed in the program was low-
fat by the standards of national dietary guidelines. This 
was achieved by encouraging participants to move to-
wards a whole food, plant-based diet ad libitum, with 
emphasis on the consumption of whole-grains, legumes, 
fresh fruits and vegetables. This diet was recommended in 
order to achieve a daily target of fewer than 20% of calo-
ries from fat and less than 10 teaspoons of added sugar, 
one teaspoon of salt (87 mmol of sodium) and 129 umol 
of cholesterol. Participants were also encouraged to con-
sume 2-2.5 L of water daily.  
 
Outcomes 
Before participating in the CHIP intervention (baseline) 
and then again at 30 days (post-intervention), partici-
pants’ height, weight, and blood pressure were taken. In 
addition, fasting (12-hour) blood samples were collected 
by trained phlebotomists and analysed for TC, LDL, HDL, 
HDL subfractions, TG and FPG concentrations. 
At baseline and again at 30 days, participants were also 
asked to complete a personal behaviour questionnaire 
with self-reported diet and physical activity, to assess 
compliance to the principles advocated by the CHIP in-
tervention. Regarding physical activity, participants were 
asked to indicate how many times per week they per-
formed at least 30 minutes of light, moderate or strenuous 
activities. Similarly, with diet, participants were asked to 
indicate how many serves of 21 different foods were con-
sumed per week or per day (whichever was more appro-
priate) on average in the preceding 2 weeks. The foods 
included to measure dietary compliance to the CHIP prin-
ciples included whole grain cereals, processed cereals, 
meat, fish, eggs, nuts/seeds, dairy, dairy alternatives, leg-
umes, potatoes, other vegetables, vegetable soup, salads, 
fruit, sweet snacks/desserts, fast/take away foods, fruit 
juice, caffeinated drinks, soft drinks/cordials, alcohol and 
water.  
 
HDL fractionation 
The Quantimetrix Lipoprint SystemTM HDL Subfrac-
tions Kit (Redondo Beach, CA; Catalog No. 48-9002) 
was used to separate and measure HDL cholesterol sub-
fractions, using the 4-30% gradient polyacrylamide gel 
tube electrophoresis method. This method was able to 
resolve up to ten subfractions of HDL, which were 
grouped into three categories: Large HDL subfractions 1-
1004                                 LM Kent, RS Grant, G Watt, DP Morton, PM Rankin and EJ Ward 
3, Intermediate HDL subfractions 4-7 and Small HDL 
subfractions 8-10, relative to particle size.  
 
Data analysis 
The data were analysed using IBM™ Statistics (version 
19) and expressed as mean ± standard deviation (SD). 
Personal behaviour was assessed by average weekly self-
reported physical activity performed for at least 30 
minutes and average dietary intake, including alcohol 
consumed over the last 2 weeks, through categorical fre-
quency questionnaires. Smoking status was assessed by 
the questions relating to never smoking, past smoking 
(including years since quitting) and current smoking (in-
cluding average cigarettes smoked per day). Physical ac-
tivity was measured by converting the three categorical 
variables of light, moderate and strenuous physical activi-
ty into separate continuous variables and then summing 
these to give a weekly frequency physical activity per-
formed for at least 30 minutes. For dietary intake the cat-
egorical variables of 19 separate foods and drinks were 
converted to continuous variables by determining the 
midpoint of the range for each category and then sum-
ming the frequency of intake to create three separate 
scales: 1. plant foods (wholegrain cereals, nuts, dairy al-
ternatives, legumes, potatoes, other vegetables, salad, 
vegetable soup and fruit), 2. energy foods (processed ce-
reals, sweets. fast food, juice, soft drinks, caffeinated 
drinks) and 3. animal foods (meat, fish, eggs, dairy).  A 
continuous variable for alcohol was also created by the 
method used for the FFQ described above. The extent of 
changes (baseline to post-intervention) in the biometric 
risk factors and behavioural factors was assessed using 
paired t-tests. The relationships between 30-day and 
change in HDL subfractions, were separately explored 
with the other biometrics, diet and physical activity using 
ANCOVA. The changes in each of the HDL subfractions 
were explored as these self-control for variation in base-
line and 30-day HDL subfractions. Three ANCOVA 
models (one analysis for each HDL subfraction) - control-
ling for age, gender, relevant baseline HDL subfraction, 
as well as change in physical activity, diet scales, BMI 
and lipids were then conducted. As FPG was highly cor-
related with BMI (r=0.827, p<0.001) and TC was highly 
correlated with LDL (r=0.955, p<0.001), FPG and TC 
were not added to the regression model. In order to ex-
plore the direction of change in the relationships found 
between the separate HDL subfractions, and other lipid 
biometrics, diet and physical activity, these were charac-
terised by whether the HDL subfraction increased or de-
creased and then examined using Pearson product-
moment correlation coefficient. For all analyses, results 
were considered significant at p<0.05. 
 
RESULTS 
Cohort demographics 
Ten men and 12 women commenced and completed the 
30-day intervention. There was no significant difference 
in the age of male and female participants (53.1±19.1 
versus 57.3±14.2, p=0.565). Of these 22 participants, 17 
had never smoked, while five were former smokers 
(range in years since quitting: 4-43 years). Twenty one of 
the participants never consumed any type of alcohol, with 
the remaining participant reduced their consumption from 
5 drinks per week at baseline to one per week at 30 days.  
 
Biometrics 
Significant mean reductions were recorded in six of the 
eight biometric risk factors (including HDL) at 30 days, 
with the exception of diastolic blood pressure (DBP) (al-
most reached significance) and TG (Table 1). Participants 
with the highest initial concentrations of HDL (≥1.3 
mmol/L versus <1.3 mmol/L) experienced the greatest 
decreases in HDL in the 30 days [0.21±0.13 mmol/L 
(11.3%, n=12) versus 0.10±0.08 mmol/L (9.1%, n=10); 
p=0.035].  
 
HDL and its subfractions  
Intermediate HDL comprised the greatest concentration 
of subfractions at baseline and 30 days, with small HDL 
the lowest concentration (Table 2). All three HDL sub-
fractions decreased over the 30 day intervention, with the 
greatest relative decrease in small HDL (-22.7%) and the 
smallest decrease in intermediate HDL (-8.3%)  (Table 
2). 
 
Relationships between 30-day HDL subfractions, bio-
metrics and behavioural factors  
All participants completed the 30-day CHIP intervention. 
Mean physical activity of at least 30 minutes at a time 
increased by more than 20% over the 30 days (Table 1). 
The majority of participants (87%) made 17 of 21 (80%) 
changes towards the recommendations of the CHIP inter-
vention to increase plant foods and decrease animal and 
energy foods. Overall frequency of consumption of plant 
foods increased about 14%, while animal and energy 
foods decreased by more than 40% over the 30 days (Ta-
ble 1).  
As there were no participants who were current smok-
ers and all former smokers had quit at least 4 years prior 
to the study, the ANCOVA model was not adjusted for 
smoking. Nor was it adjusted for alcohol consumption as 
there was only one drinker who reduced their consump-
tion from five drinks per week to one drink. After adjust-
ing for age, sex, BMI, TG, LDL, 30-day plant foods, an-
imal foods and energy foods, and baseline concentrations 
of the respective HDL subfraction, the baseline subfrac-
tion measure was the largest predictor of the correspond-
ing 30 day intermediate and large subfraction measure. 
For small HDL, the baseline HDL subfraction, was the 
largest predictor of 30-day small HDL after age (Table 3). 
In addition to baseline concentrations, 30-day TG was an 
inverse predictor of 30-day large HDL, while 30-day an-
imal foods was a positive predictor and 30-day energy 
foods an inverse predictor of 30-day small HDL (Table  
3). 
 
Relationships between change in HDL subfractions, 
biometrics and behavioural factors 
For small HDL, age and baseline small HDL were found 
to be inverse predictors of change (Figure 1, Table 4). For 
intermediate HDL, change in LDL directly predicted 
change in this subfraction, while change in plant foods 
was an inverse predictor (Figure 1, Table 4). For large 
HDL, change in TG was an inverse predictor and change 
                                                                                                                             CHIP and HDL subfractions                                                                                                                       1005                                                            
 
Table 1. Mean changes in selected risk factors 
 
Biometric 
Participants 
(n) 
Baseline  30 day 
Mean change 95% confidence interval % change t statistic p value 
Mean SD  Mean SD 
BMI (kg/m2) 22 29.8 9.95  29.1 9.41 -0.74 -1.39, -0.09 -2.5 -2.36 0.028 
SBP (mmHg) 22 137 31.9  127.3 22. 5 -9.68            -16.0, -3.35 -7.1 -3.18 0.005 
DBP (mmHg) 22 77.1 11.8  72.8 7.52 -4.27 -8.75, 0.20 -5.5 -1.99 0.060 
TC (mmol/L) 22 4.94 1.07  4.47 0.95 -0.47 -0.74, -0.20 -9.5 -3.59 0.002 
LDL (mmol/L) 22 2.84 0.92  2.52 0.76 -0.32 -0.54, -0.10 -11.2 -3.01 0.007 
HDL (mmol/L) 22 1.51 0.55  1.35 0.50 -0.16 -0.21, -0.11 -10.6 -6.24 <0.001 
TG (mmol/L) 22 1.29 0.63  1.32 0.69 0.02 -0.17,  0.21 1.6 0.23 0.820 
FPG (mmol/L) 22 5.69 1.53  5.22 1.11 -0.46 -0.87, -0.05 -8.2 -2.36 0.028 
Physical activity 22 8.34 3.20  10.23 3.87 1.89 0.39,  3.38 22.7 2.26 0.016 
Plant foods 22 44.3 17.9  50.4 14.2 6.14 0.54, 11.74 13.9 2.28 0.003 
Non-plant† 22 11.9 9.04  6.75 8.27 -5.11 -8.84, -1.39 -43.1 -2.86 0.009 
 
BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure, TC: Total cholesterol; LDL; Low-density cholesterol; HDL: High-density cholesterol, TG: Triglycerides; FPG: Fasting plasma 
glucose 
†Non-plant refers to animal and energy foods combined. 
 
 
Table 2. Mean changes in HDL subfractions (mg/dL) 
 
HDL particle size Participants (n) 
Baseline  30 day 
Mean change 95% confidence interval % change t statistic p value 
Mean SD  Mean SD 
Large  22 19.5 12.4  17.5 12.8 -1.95 -3.18, -0.73 -10.0 -3.31 0.003 
Intermediate  22 31.3 8.45  28.7 7.19 -2.59 -3.91, -1.27 -8.3 -4.09 0.001 
Small  22 7.82 2.91  6.05 2.79 -1.77 -2.93, -0.61 -22.7 -3.18 0.005 
 
 
Table 3. Statistically significant demographic, behavioural and biometric associates of 30-day HDL subfractions 
 
HDL subfraction  Associates† F p B (95% CI) ƞ2 (%)‡ 
30-day Large HDL Baseline large HDL 510 <0.001 0.977 (0.886, 1.07) 96.4 
30-day TG 10.8 0.004 -2.53 (-4.15, -0.916) 36.2 
      
30-day  Intermediate HDL Baseline intermediate HDL 152 <0.001 0.801 (0.666, 0.936) 88.4 
      
30-day Small HDL Age 21.0 <0.001 -0.105 (-0.154, -0.057) 55.2 
Baseline small HDL 14.8 0.001 0.468 (0.208, 0.728) 45.8 
30-day energy foods 4.81 0.043 -0.216 (-0.424, -0.008) 22.0 
30-day animal foods 7.84 0.012 0.440 (0.109, 0.772) 31.6 
 
†Covariates in ANCOVA models - Age, sex, BMI, baseline concentration of the relevant subfraction, the energy foods, animal foods and plant foods scales, and 30-day BMI, LDL and TG. 
‡Ƞ2 partial eta square. 
 
1006                                 LM Kent, RS Grant, G Watt, DP Morton, PM Rankin and EJ Ward 
in physical activity a direct predictor of change in this 
subfraction (Figure 1, Table 4). 
We then explored the lipid and behaviour relationships 
found for intermediate and large HDL by whether these 
subfractions increased or decreased. For participants 
where large HDL decreased there was a strong inverse 
correlation with TG (r=-0.564, p=0.029, n=15), but this 
was not found for participants where large HDL increased 
(r=-0.001, p=0.999, n=7). We also found a strong, but not 
significant correlation with physical activity among par-
ticipants where large HDL increased (r=0.684, p=0.090, 
n=7), but not where large decreased (r=-0.116, p=0.680, 
n=15). For participants where intermediate HDL de-
creased or increased, no significant relationships were 
found with change in LDL (r=0.247, p=0.357, n=16 and 
r=0.133, p=0.802, n=6, respectively). However, a strong 
positive correlation was found between increases in in-
termediate HDL and plant foods (r=0.862, p=0.027, n=6), 
but not with decreases in this HDL subfraction (r=-0.077, 
p=0.775, n=16). 
 
DISCUSSION 
This study confirms our previous findings that when indi-
viduals move towards a low fat, plant-based diet with 
physical activity, HDL concentrations of the majority 
tend to decrease while all other measures of cardiovascu-
lar risk improve, except for TG.19 These findings are also 
supported by other epidemiological and clinical studies.7,8 
However, it is not clear why TG did not change in this 
study. A meta-analysis of personal behaviour interven-
tions incorporating low fat-high carbohydrate diets, also 
found an overall increase in TG concentrations.21 It was 
suggested that weight loss mobilises energy stored as fat 
(triglycerides) into the bloodstream, which appear to 
normalise over time.22 Furthermore, carbohydrate intake 
is associated with increased TG.23  
When we explored the effects of the CHIP intervention 
on HDL subfractions, we found that among individuals 
where HDL decreased, intermediate HDL was the most 
abundant at baseline and post-intervention, with small 
HDL the least abundant. This is supported by the findings 
of Sabaka et al.24 However, other studies, including the 
Diabetes Prevention Program (DPP) have shown that 
small HDL is the most abundant subfraction compared to 
large HDL by a ratio of three or more to one.13,25,26 In the 
present study, the concentration of large to small HDL 
particles at 30-days was almost three to one, the reverse 
found in  the DPP program. We also found that all three 
HDL subfractions decreased at 30 days, with the decrease 
in small HDL being about fivefold greater than the de-
crease in large or intermediate HDL. However, DPP 
found a 5% decrease in small HDL and together with the 
PREDIMED (Prevention with Mediterranean diet) study, 
reported increases in large HDL (17-24%) following their  
programs.25,27  
Traditionally, the Mediterranean diet is high in unpro-
cessed plant foods (grains, vegetables, fruits, legumes, 
nuts/seeds and extra virgin olive oil), moderate in 
 
 
 
Figure 1. Observed determinants (as reported in Table 4) of change in HDL sub-fractions at 30 days. †β - Parameter estimate. 
 
 
Table 4. Statistically significant demographic, behavioural and biometric associates of change in HDL subfractions 
 
HDL subfraction Associates† F p B (95% CI) ƞ2 (%)‡ 
Change in Large HDL Change in TG 15.5 0.001 -4.10 (-6.28, -1.92) 44.9 
Change in physical activity 4.44 0.049 0.277 (0.002, 0.552) 18.9 
      
Change in Intermediate HDL Change in LDL 18.6 <0.001 3.59 (1.84, 5.34) 50.8 
Baseline intermediate HDL 25.6 <0.001 -0.255 (-0.360, -0.149) 58.7 
Change in plant foods 5.07 0.037 -0.077 (-0.149, -0.005) 22.0 
      
Change in Small HDL Age 13.0 0.002 -0.090 (-0.143, -0.038) 40.6 
Baseline small HDL 14.8 0.01 -0.541 (-0.836, -0.246) 43.7 
 
†Covariates in ANCOVA models - Age, sex, BMI, baseline concentration of the relevant subfraction, the energy foods, animal foods and 
plant foods scales, and 30-day BMI, LDL and TG. 
‡Ƞ2 partial eta square. 
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fish/shellfish and wine and low in meat, dairy, eggs, ani-
mal fats and discretionary foods.28 On the other hand, the 
CHIP diet is a whole food, plant-based diet, with empha-
sis on the consumption of whole-grains, legumes, fresh 
fruits and vegetables, consumed ad libitum. The DPP did 
not specify a diet type other than to instruct the partici-
pants to choose low calorie and fat substitutes at each 
concentration of the US Department of Agriculture Food 
Guide Pyramid, in order to achieve the weight reduction 
goal of 7% of initial body weight, while also incorporat-
ing 150 minutes per week of moderate physical activity.29 
The PREDIMED study was not able to explain which 
portion of the Mediterranean diet facilitated the increase 
in large HDL In the PREDIMED study, total HDL in-
creased 4%, while all other biometrics showed minimal 
decreases, except TG, which decreased 12% after one 
year.27 In the DPP group, total HDL increased 3%, while 
all other biometrics showed greater decreases than that of 
the PREDIMED study after one year.25 However, the 
decreases in biometrics in both these studies were not as 
great as were found in the present study, except for TG. It 
would appear the different dietary and personal behaviour 
patterns have differing effects on lipids and HDL subfrac-
tions. 
The relationship becomes more complex when baseline 
HDL and changes in HDL following the CHIP interven-
tion are considered, as decreases in HDL were greater 
when baseline HDL was higher. In terms of metabolic 
syndrome (MetS) risk factors, the participants in the pre-
sent study started the program with two of the five classic 
markers for MetS, BMI and FPG; BP, HDL and TG were 
within the healthy range. By 30 days, FPG had normal-
ised, reducing the number of MetS markers to one. Partic-
ipants in the PREDIMED and DPP studies commenced 
their programs with four of the classic markers for MetS 
(BMI, BP, HDL and FPG versus BMI, HDL, TG and 
FPG (BP was not measured in DPP); respectively).25,27 By 
the end of one year, all elevated risk factors remained 
elevated in both studies, except for TG in the DPP group, 
which normalised. Furthermore, baseline concentrations 
of LDL were higher in these studies than the present 
study (3.80 mmol/L, 3.21 mmol/L and 2.84 mmol/L; re-
spectively). Exploring baseline and the changes in the 
various risk factors may help to explain the observed 
changes in HDL and its subfractions in the PREDIMED, 
DPP and the present study. Certainly, in the present study, 
baseline concentrations of some HDL subfractions were 
strong predictors of change in these subfractions. 
Large HDL is processed or catabolised by direct uptake 
into the liver by scavenger receptor class B1; by undergo-
ing lipolysis by lipases; or by exchange of its cholesteryl 
ester for TG from apoB-containing lipoproteins via cho-
lesterol ester transfer protein (CETP) (apoB is then taken 
up by LDL receptors on the hepatocytes).12  The transfer 
via CETP is believed to occur under conditions of elevat-
ed TG, resulting in HDL particles that are susceptible to 
hydrolysis by hepatic lipase and reduced plasma HDL 
concentrations. Consistent with this, we found an inverse 
association between TG and 30-day large HDL and 
changes in large HDL in this study.   
In terms of antioxidant activity, one proposed role of 
small HDL is to protect LDL from oxidation.12 LDL, in 
particular oxidised LDL, is associated with CVD and 
CHD. Given that the dietary regime in the present study 
was principally low-fat and plant-based with an abun-
dance of antioxidants, it is expected that LDL is less like-
ly to be oxidised. Together with the low-fat intake, the 
requirement for small HDL for RCT would be lower as 
LDL is less likely to accumulate in arterial wall macro-
phages. Indeed, of all the HDL subfractions, we found the 
greatest decrease in small HDL. Furthermore, we found 
that LDL decreased to normal levels following the inter-
vention, while LDL only marginally decreased in the DPP 
and PREDIMED studies, remaining elevated in both in-
terventions (small HDL also only marginally decreased or 
remained steady in these studies). Whilst we did not find 
an association between small HDL and plant foods in the 
present study, we found a direct relationship between 
small HDL and animal foods. However, we did find a 
direct relationship between intermediate HDL and plant 
foods but the implications of this relationship are yet to 
be determined. 
HDL particles may also differ between individuals with 
different personal behaviours. Alcohol is more strongly 
correlated with small HDL than large HDL.30 In the pre-
sent study, all participants either did not drink alcohol or 
significantly reduced consumption to less than one serve 
per week, which may also explain the decrease in small 
HDL. It is also well recognised that physical activity in-
creases HDL.31 HDL subfractions may also respond dif-
ferently to physical activity. Campbell et al (2011), found 
that large HDL increased and small HDL decreased with 
continuous or intermittent exercise, being mediated 
through increases in lecithin cholesterol acyl transferase 
activity, involved in esterifying the cholesterol in the 
HDL particle, so that more can be taken up, thereby in-
creasing its size.32 In the present study, physical activity 
increased by more than 20% and a direct relationship was 
found between physical activity and large HDL. 
Personal behaviour choice can be complex and inter-
ventions to address chronic disease risk factors are heter-
ogeneous. Furthermore, the variety of techniques used to 
fractionate (and damage) lipid fractions, based on density, 
size and charge, produces different particle profiles.11 In 
addition, HDL is complex, with greater variation in struc-
ture, protein composition and physiological function than 
LDL.12,33,34 Given that disease states and behavioural fac-
tors can affect the remodelling of this family of particles, 
it is therefore not surprising that outcomes observed 
across studies create conflicting data on the role of HDL 
subpopulations on CHD, atherosclerosis and the metabo-
lism of cholesterol.35 
 
Strengths and Limitations 
The strengths of this study are that the overall 30-day 
biometric results are comparable to other studies of the 
CHIP intervention delivered by both health professionals 
and trained volunteers in the United States and Australa-
sia,36-39 as well as comparing favourably to other profes-
sionally delivered behavioural interventions.40-42 This 
study is novel in that it presents changes in HDL subfrac-
tions that differ from other published studies and may be 
explained by the dietary regimen. Another strength of the 
study is that biometrics were not self-reported but meas-
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ured by the same health professionals using the same 
equipment at baseline and 30 days. 
A major limitation of this study is that a reference 
group was not included. Hence we are not able to deter-
mine whether the changes in HDL subfractions were due 
to the intervention or some other unrelated factor. Anoth-
er limitation is that self-reported personal behaviours, 
such as dietary intake and physical activity, carry bias and 
therefore may have been inadequately measured in the 
study. Nevertheless, we were concerned with changes in 
behavioural measures. Given that the participants com-
pleted the same questionnaire pre- and post-intervention 
the reporting bias may have been reduced. Furthermore, 
the relatively small sample size resulted in many associa-
tions though strong, not reaching statistical significance. 
Further investigation on a larger cohort is warranted. A 
further limitation was the short follow-up time after 
which the benefits gained by both groups may have been 
lost or diminished, such as in the DPP and PREDIMED 
studies. A small New Zealand study found that 106 CHIP 
participants who returned for follow-up assessment, on 
average 4 years after completion of the intervention, were 
able to maintain improvements in most of their biomet-
rics.43 
 
Conclusion 
The literature supports an important role for HDL in ame-
liorating the risk of CVD, but the role of the various sub-
fractions in this process is still unclear as HDL is a highly 
complex molecule, both structurally and functionally. The 
results of this study have provided some valuable insights. 
We found that HDL decreases as individuals move to-
wards a low-fat, plant-based diet, with physical activity. 
However, our observation that the individual HDL sub-
fractions (small, intermediate and large) decrease with a 
plant based diet and physical activity, and are dependent 
on baseline lipid concentrations, is novel. Furthermore, 
these HDL subfractions respond differentially to different 
behavioural factors. 
Additional research is required to clarify the role 
played by disease processes and various behavioural ther-
apies in modelling and re-modelling the proteome and 
lipidome of the HDL particle and to extend our 
knowledge of the functional properties of HDL and its 
various subfractions. This and the development of non-
destructive standardised biochemical techniques to differ-
entiate all the HDL subfractions will also aid in providing 
consistent information on the functional properties of 
particles and assist in developing therapies to support 
individuals with a range of chronic disease risk factors. 
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